SCHEMBL1033923

SCHEMBL1033923

Clc1cc(Cl)cc(-c2ccnc(NC3CCCCC3)n2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 4/20 0.59
MAPK10 P53779 4/20 0.58
MAPK8 P45983 3/20 0.58
MAPK9 P45984 3/20 0.58
EIF2AK2 P19525 1/20 0.57
CDK1 P06493 5/20 0.52
CCNB1 P14635 5/20 0.52
CDK4 P11802 3/20 0.52
CCNA2 P20248 3/20 0.52
CCND1 P24385 3/20 0.52
CDK2 P24941 3/20 0.52
CCNA1 P78396 3/20 0.52
CTSK P43235 1/20 0.51
CCNB2 O95067 2/20 0.50
CCNB3 Q8WWL7 2/20 0.50
ADORA1 P30542 1/20 0.50
CDC7 O00311 1/20 0.50
PLK4 O00444 1/20 0.50
JAK2 O60674 1/20 0.50
MAP4K4 O95819 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3619159 0.88 ADORA1 (0.59) IKBKBMAPK10MAPK8MAPK9EIF2AK2
SCHEMBL1030530 0.88 ADORA1 (0.59) IKBKBMAPK10MAPK8MAPK9EIF2AK2
SCHEMBL1032138 0.87 IKBKB (0.76) IKBKBMAPK10MAPK8MAPK9EIF2AK2
SCHEMBL1031885 0.83 CDK1 (0.52) IKBKBMAPK10MAPK8MAPK9CDK1
SCHEMBL2389822 0.83 IKBKB (0.55) IKBKBMAPK10MAPK8MAPK9EIF2AK2
SCHEMBL5819449 0.81 ADORA1 (0.52) IKBKBMAPK10MAPK8MAPK9EIF2AK2
SCHEMBL1034791 0.81 MAPK1 (0.54) IKBKBMAPK10MAPK8MAPK9CDK1
SCHEMBL1029918 0.80 MAPK8 (0.60) IKBKBMAPK10MAPK8MAPK9EIF2AK2
SCHEMBL1033674 0.80 CDK1 (0.57) IKBKBMAPK10MAPK8MAPK9EIF2AK2
SCHEMBL5823374 0.79 ADORA1 (0.53) IKBKBMAPK10MAPK8MAPK9EIF2AK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed